Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-11-4
pubmed:abstractText
Results obtained in the first year of active surveillance of serious diseases caused by group A streptococci in the Czech Republic carried out within the Strep-EURO project are summarized. From January to December 2003, 28 Czech laboratories referred to the National Institute of Public Health 59 group A streptococcal strains isolated from invasive diseases meeting the Strep-EURO definition. At the same time, clinical-epidemiological data and information on the catchment area population were provided. For 2003, the total morbidity and case fatality rates were calculated to be 1.3/100,000 population and 13.5%, respectively. A high proportion (23.7%) of the 59 strains were of type emm 1, initially labeled M1. As many as 24.1%, 17.2% and 20.7% of the strains tested were resistant to erythromycin, clindamycin and tetracycline, respectively. The seemingly lower morbidity rate and higher case fatality rate from serious diseases caused by group A streptococci reported in the Czech Republic for 1994-1996, i.e. 0.4/100,000 and 46.5%, respectively, in comparison with the latest data can be explained by the use of softer international criteria for the Strep-EURO definition of invasive disease.
pubmed:language
cze
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1210-7913
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
106-11
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
[Surveillance of serious diseases caused by group A streptococci in the Czech Republic in 2003--the Strep-EURO project].
pubmed:affiliation
Centrum epidemiologie a mikrobiologie, Státní zdravotní ústav, Praha.
pubmed:publicationType
Journal Article, English Abstract, Research Support, Non-U.S. Gov't, Multicenter Study